CIPHER PHARMACEUTICALS INC (CPH.CA) Stock Balance Sheet
TSX:CPH - Toronto Stock Exchange - CA17253X1050 - Common Stock - Currency: CAD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 39.83M | 28.80M | 20.50M | 9.10M | |||
| Cash Equivalents | 17.84M | N/A | N/A | N/A | N/A | |||
| Receivables | 13.86M | 5.09M | 6.80M | 6.70M | 9.20M | |||
| Inventories | 5.79M | 2.98M | 2.20M | 1.70M | 900.00K | |||
| Other Current Assets | 995.00K | 378.00K | 400.00K | 500.00K | 900.00K | |||
| Total Current Assets | 38.48M | 48.27M | 38.20M | 29.30M | 20.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 680.00K | 402.00K | 500.00K | 500.00K | 1.90M | |||
| Goodwill | 17.45M | 15.71M | 15.70M | 15.70M | 15.70M | |||
| Intangibles | 78.75M | 1.76M | 2.80M | 3.60M | 4.20M | |||
| Other Non-Current Assets | 27.15M | 19.89M | 16.70M | 2.50M | 2.40M | |||
| Total Non-Current Assets | 124.03M | 37.76M | 35.60M | 22.40M | 24.20M | |||
| TOTAL ASSETS | 162.51M | 86.03M | 73.80M | 51.70M | 44.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 283.00K | 94.00K | 100.00K | 100.00K | 100.00K | |||
| Accrued Expenses | 358.00K | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 5.87M | 4.64M | 4.10M | 5.60M | 6.80M | |||
| Other Current Liabilities | 13.36M | 519.00K | 5.20M | 6.70M | 3.00M | |||
| Total Current Liabilities | 19.87M | 5.25M | 9.40M | 12.30M | 9.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 40.30M | 259.00K | 300.00K | 500.00K | 1.70M | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 40.30M | 259.00K | 300.00K | 500.00K | 1.70M | |||
| TOTAL LIABILITIES | 60.17M | 5.51M | 9.70M | 12.80M | 11.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 77.65M | 66.27M | 50.50M | 25.20M | 18.40M | |||
| Additional Paid In Capital | 6.53M | 5.75M | 5.40M | 5.10M | 5.10M | |||
| Common Shares | 27.68M | 18.01M | 17.70M | 18.10M | 18.70M | |||
| Other Shareholders' Equity | -9.51M | -9.51M | -9.50M | -9.50M | -9.50M | |||
| Shares Outstanding | 25.60M | 23.99M | 25.10M | 25.90M | 27.00M | |||
| Tangible Book Value per Share | 0.24 | 2.63 | 1.82 | 0.76 | 0.47 | |||
| Total Shareholders' Equity | 102.34M | 80.52M | 64.10M | 38.90M | 32.60M | |||
| TOTAL LIABILITIES AND EQUITY | 162.51M | 86.03M | 73.80M | 51.70M | 44.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.39 | 0.00 | 0.00 | 0.01 | 0.05 | |||
| Current Ratio | 1.94 | 9.19 | 4.06 | 2.38 | 2.03 | |||
| Return On Assets (ROA) | 7.10% | 23.69% | 36.10% | 15.01% | 10.27% | |||
| Return On Equity (ROE) | 11.28% | 25.31% | 41.56% | 19.95% | 13.96% | |||
| Return On Invested Capital (ROIC) | 3.96% | 8.94% | 12.35% | 23.87% | 25.47% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 4.53% | 8.94% | 12.35% | 23.87% | 25.47% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 19.76% | 11.41% | 17.33% | 46.78% | 60.43% | |||
All data in USD , ROIC based on taxRate of 0.28